Assessing whether there is a cancer premium for the value of a statistical life.

Published

Journal Article

This article estimates whether there is a cancer risk premium for the value of a statistical life using stated preference valuations of cancer risks for a large, nationally representative US sample. The present value of an expected cancer case that occurs after a one decade latency period is $10.85m, consistent with a cancer premium that is 21% greater than the median value of a statistical life estimates for acute fatalities. This cancer premium is smaller than the premium proposed for policy analyses in the UK and the USA. There is also a greater premium for policies that reduce cancer risks to zero and for risk reductions affecting those who perceive themselves to have a greater than average probability of having cancer.

Full Text

Duke Authors

Cited Authors

  • Viscusi, WK; Huber, J; Bell, J

Published Date

  • April 2014

Published In

Volume / Issue

  • 23 / 4

Start / End Page

  • 384 - 396

PubMed ID

  • 23520055

Pubmed Central ID

  • 23520055

Electronic International Standard Serial Number (EISSN)

  • 1099-1050

International Standard Serial Number (ISSN)

  • 1057-9230

Digital Object Identifier (DOI)

  • 10.1002/hec.2919

Language

  • eng